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Introduction
The type I family of transmembrane receptor tyrosine kinases
comprises four members: epidermal growth factor receptor
(EGFR or ErbB1), ErbB2 (HER2 or Neu), ErbB3 and ErbB4
(Alroy and Yarden, 1997; Yarden and Sliwkowski, 2001). ErbB
proteins engage in an extensive network of homo- and
heteroassociations resulting in signal diversification (Tzahar et
al., 1996). The relative expression levels of the various
receptors and the concentrations of their respective ligands
determine the composition of homo- and heterodimers (Pinkas
Kramarski et al., 1996; Graus Porta et al., 1997). ErbB2 is the
preferred heteroassociation partner of all other ErbB proteins,
enhancing ligand binding affinity and signaling potency by
virtue of its potent latent kinase activity (Karunagaran et al.,
1996). Activation-induced endocytosis and downregulation are
important in limiting the duration of receptor activation, but
their efficiency is low for all members of the ErbB family with
the exception of ErbB1 (Baulida et al., 1996). This is probably
due to impaired coupling of cbl, a protein thought to be
involved in activation-induced degradation, to ErbB2, ErbB3
and ErbB4 (Levkowitz et al., 1996). The significance of ErbB2
is underscored by its overexpression in about 30% of breast
carcinomas, a phenomenon associated with poor prognosis
(Slamon et al., 1987).
The signaling network of ErbB proteins is based on receptor
homo- and heterodimers. In addition to these small-scale
associations, higher order associations involving large-scale
clusters of ErbB2 have also been identified (Nagy et al.,
1999b). These clusters contain hundreds of ErbB2, are ~0.5 m m
in diameter, a size that increases upon ErbB2 activation. The
significance of such large-scale protein clusters probably
results from the high local concentration of ErbB and other
signaling proteins facilitating the formation of receptor
complexes (Nagy et al., 1999a).
ErbB2 plays an important role in the development and
progression of many breast cancers and other malignancies
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The ErbB family of transmembrane receptor tyrosine
kinases plays an important role in the pathogenesis of many
cancers. The four members of the family, ErbB1-4, form
various homo- and heterodimers during the course of
signal transduction. A second hierarchical level of
molecular associations involving 102-103 molecules, termed
large-scale clustering, has also been identified, but the
regulatory factors and biological consequences of such
structures have not been systematically evaluated. In this
report, we describe the states of association of ErbB2 and
their relationship to local ErbB3 density and lipid rafts
based on quantitative fluorescence microscopy of SKBR-3
breast cancer cells. Clusters of ErbB2 colocalized with lipid
rafts identified by the GM1-binding B subunit of cholera
toxin. Pixel-by-pixel analysis of fluorescence resonance
energy transfer between labeled antibodies indicated that
the homoassociation (homodimerization) of ErbB2 was
proportional to the local density of ErbB2 and inversely
proportional to that of ErbB3 and of the raft-specific lipid
GM1. Crosslinking lipid rafts with the B subunit of cholera
toxin caused dissociation of the rafts and ErbB2 clusters,
an effect that was independent of the cytoskeletal
anchoring of ErbB2. Crosslinking also decreased ErbB2-
ErbB3 heteroassociation and the EGF- and heregulin-
induced tyrosine phosphorylation of Shc. When cells were
treated with the anti-ErbB2 monoclonal antibody 4D5
(parent murine version of Trastuzumab used in the
immunotherapy of breast cancer), internalization of the
antibody was inhibited by crosslinking of lipid rafts, but
the antiproliferative activity of 4D5 was retained and even
enhanced. We conclude that local densities of ErbB2 and
ErbB3, as well as the lipid environment profoundly
influence the association properties and biological function
of ErbB2.
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(Park et al., 2000). An anti-ErbB2 monoclonal antibody, 4D5,
inhibits the proliferation of tumor cells that overexpress ErbB2
(Sarup et al., 1991). The humanized version of 4D5
(Trastuzumab, Herceptin™) has significant anticancer activity
(Cobleigh et al., 1999; Slamon et al., 2001). Its exact
mechanism of action is as yet unclear. The antibody induces
partial tyrosine phosphorylation of ErbB2 but does not activate
the MAP kinase pathway, although it does activate the cyclin-
dependent kinase inhibitor p27KIP (Sliwkowski et al., 1999).
It has been proposed that the antiproliferative activity of
Trastuzumab is due largely to the downmodulation of surface
ErbB2 by receptor-mediated endocytosis (Sarup et al., 1991;
Sliwkowski et al., 1999). Cbl-mediated ubiquitination is
thought to play a key role in this process (Klapper et al., 2000;
Levkowitz et al., 2000). Antibodies that efficiently internalize
ErbB2 but fail to inhibit tumor cell proliferation have also been
identified (Neve et al., 2001), suggesting that antibody-
mediated internalization may not be a good marker of anti-
tumor activity.
Higher order associations (i.e. the organization of individual
and oligomeric membrane proteins into several hundred-
nanometer-scale complexes) have attracted increased attention
in studies of receptor biology and signal transduction.
Membrane domains are often thought of as organizing forces
beyond such associations. For example, lipid rafts,
sphingolipid- and cholesterol-rich membrane microdomains,
participate in diverse cellular functions such as membrane
trafficking and receptor signaling (Simons and Ikonen, 1997;
Janes et al., 1999). There is intense debate about the size and
nature of lipid rafts, but recent evidence supports the existence
of small (<0.1 m m in diameter) lipid rafts that can dynamically
associate with each other to form larger signal transducing
platforms (Harder and Simons, 1997; Kurzchalia and Parton,
1999; Pralle et al., 2000; Edidin, 2001; Anderson and
Jacobson, 2002). Lipid rafts and a special form thereof,
caveolae, are thought to be involved in EGFR-mediated
signaling (Furuchi and Anderson, 1998; Mineo et al., 1999)
presumably by altering the activity of protein kinases
(Ilangumaran et al., 1999) and changing the association state
of membrane proteins (Bodnár et al., 1996; Vereb et al., 2000;
Matkó et al., 2002).
We have previously reported the existence of plasma
membrane domains in which the homoassociation of ErbB2 is
unusually high (Nagy et al., 1998). The significance of this
finding is underlined by the fact that overexpression-driven
constitutive homoassociation of ErbB2 induces ligand-
independent activation of ErbB2 and other ErbB proteins
(Worthylake et al., 1999). Although the overall effect of
changes in the relative expression levels of ErbB proteins has
already been studied (Tzahar et al., 1996), the role of local
differences in the relative densities of receptors, which may
explain differences in the association of proteins within a single
cell (Chamberlin and Davies, 1998), has not been previously
addressed. In our current experiments we show that membrane
domains with high degree of ErbB2 homoassociation have high
ErbB2 and low ErbB3 densities. The association state of ErbB2
is also influenced by lipid rafts. ErbB2 is dislodged from the
latter after crosslinking GM1, a raft-associated ganglioside
(Harder et al., 1998), by the B subunit of cholera toxin (CTX-
B), which is associated with decreased ErbB2-ErbB3
heterodimerization and reduced tyrosine phosphorylation of
ErbB2 upon heregulin stimulation. It is of interest to point out
that 4D5-mediated internalization of ErbB2 is blocked in CTX-
B-pretreated cells, whereas the antiproliferative effect of 4D5
is not. Our results emphasize that alterations in the local
environment of ErbB2 strongly influence its association




The SKBR-3 breast tumor cell line was obtained from the American
Type Culture Collection (Rockville, MD) and grown according to its
specifications to confluency. For microscopic experiments cells were
cultured in slide chambers (Nunc, Naperville, IL), and labeled and
measured without trypsinisation. For flow cytometric measurements
cells were harvested with trypsinization.
Antibodies, growth factors
4D5 and 7C2 antibodies against the ErbB2 protein were a kind gift
from Genentech (South San Francisco, CA), and were labeled with
fluorescent dyes for FRET and for colocalization measurements. The
dye/protein ratio was 1-3 as determined by spectrophotometric
measurements. The H3.90.6 anti-ErbB3 antibody was purchased from
NeoMarkers (Fremont, CA), and the sc-894 polyclonal rabbit
antibody against caveolin was from Santa Cruz Biotechnology
(Heidelberg, Germany). Cy2-, Cy3- and Cy5-labeled polyclonal
rabbit Fab fragments against mouse IgG (anti H+L) were from
Jackson Immunoresearch (West Grove, PA). The anti-
phosphotyrosine antibody PY99 (sc-7020) and the anti-Shc antibody
(sc-967) were from Santa Cruz Biotechnology (Santa Cruz, CA) The
anti-ErbB2 antibody c-neu/Ab-3 (OP15) was from Calbiochem
(Darmstadt, Germany). Protein G-coated Sepharose ‘Fast flow’ beads
were purchased from Sigma-Aldrich (Schnelldorf, Germany).
Epidermal growth factor and the EGF-like domain of heregulin-b 1
were from R&D Systems (Minneapolis, MN). Cells were starved in
0.1% FCS-containing medium for 48 hours before stimulation with
EGF or heregulin.
Labeling of cells with antibodies and subunit B of cholera toxin
ErbB proteins were labeled with saturating concentration of
antibodies for 30 minutes on ice in PBS. Unbound antibodies were
removed by washing twice with PBS. When two primary labeled
antibodies were used to label cells, they were added simultaneously.
When one of the labelings was indirect, cells were first incubated with
the unlabeled primary antibody followed by the dye-conjugated
secondary Fab. Subsequently, cells were labeled with a labeled
primary antibody against the other antigen.
Prior to labeling caveolin, cells were fixed in 3.7% formaldehyde
(30 minutes on ice) and incubated with the sc-894 anti-caveolin
antibody in the presence of 0.1% BSA and 0.1% TritonX-100 for 30
minutes on ice followed by secondary labeling with Cy3-conjugated
F(ab¢ )2 fragment of goat anti-rabbit immunoglobulin (Jackson
Immunoresearch, West Grove, PA).
In order to label lipid rafts cells were incubated in the presence of
8 m g/ml FITC-labeled subunit B of cholera toxin (Sigma-Aldrich,
Schnelldorf, Germany) for 30 minutes on ice. For crosslinking lipid
rafts incubation with subunit B of cholera toxin was carried out at
37°C for 30 minutes.
Confocal microscopy
A Zeiss LSM410 confocal laser scanning microscope (Carl Zeiss,
Thornwood, New York) was used to image cells. Alexa488, Cy2 and
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FITC were excited with the 488 nm line of an argon/krypton ion laser
and emission from these fluorophores was detected through an FT
488/568 nm dual-band dichroic mirror and a 515-565 nm band-pass
filter. Cy3 was excited with the 568 nm line of an argon/krypton laser
and emission was detected through an FT 488/568 nm dual-band
dichroic mirror and a 575-640 nm band-pass filter. Cy5 was excited
at 647 nm and emission was measured through a FT 665 nm long-
pass dichroic mirror.
During the experiments with membrane clusters of ErbB proteins,
the focal plane of the confocal microscope was adjusted such that
either the top or the bottom flat layer of the cell membrane could be
imaged in a single confocal slice.
Donor photobleaching FRET measurements
In some of the experiments, the association of membrane proteins was
measured using the donor photobleaching FRET method (Jovin and
Arndt Jovin, 1989). Briefly, one of the proteins was labeled with a
fluorescein (donor)-labeled antibody and the other protein was labeled
with a Cy3 (acceptor)-labeled antibody (double-labeled sample).
Another sample was also prepared in which only the donor-labeled
antibody was applied (donor only sample). The kinetics of donor
photobleaching was measured in both samples. The fluorescence
intensity curves were fitted to a double exponential equation with a
custom-written program in LabView (National Instruments, Austin,
TX). An effective rate constant was calculated by taking the
amplitude-weighted time constants of the exponential terms. Any
process (e.g. FRET) competing with photobleaching slows the rate of
the process. Therefore it is possible to calculate the FRET efficiency
on a pixel-by-pixel basis by comparing the rate of donor
photobleaching in the double-labeled sample to that in the donor-only-
labeled sample according to the expression FRET=1– t eff,D/t eff,DA,
where t eff,D is the average effective photobleaching time constant in
the donor-only-labeled sample, and t eff,DA is the effective
photobleaching time constant of a pixel in the donor-acceptor double-
labeled sample. 
Acceptor photobleaching FRET measurements
This technique is based on the detection of increased donor
fluorescence intensity following irreversible photodestruction of the
acceptor (Wouters et al., 1998). A sample was labeled with Cy3- and
Cy5-tagged antibodies. First, an image was taken in the Cy3 (donor)
channel (Iq) followed by an image in the Cy5 (acceptor) channel.
Then, the acceptor was bleached completely, after which another Cy3
image was taken reporting the unquenched fluorescence intensity of
the donor (Iuq). Images were corrected for spectral spillover, and the
second Cy3 image was corrected for bleaching by the 647 nm laser
line used to bleach Cy5. The FRET efficiency was calculated
according to the equation FRET=1–Iq/Iuq.
Analysis of correlation between FRET efficiency and
fluorescence intensity
In order to correlate the FRET efficiency (measured either with the
donor or the acceptor photobleaching FRET method) with the
fluorescence intensity on a pixel-by-pixel basis, images were analyzed
with Scil-Image (University of Amsterdam, The Netherlands) after
correction for shift and spectral spillover. The correlation between
FRET efficiency and unquenched donor fluorescence intensity was
calculated and plotted according to Demandolx and Davoust
(Demandolx and Davoust, 1997).
Calculation of the overlap between clusters
Low frequency background was removed using either a Fourier
transformation based method (Hwang et al., 1998) or top-hat
transformation (Glasbey and Horgan, 1995). Low frequency
background is a constant or a smoothly changing intensity component
that may be caused by inhomogenous illumination, autofluorescence
or non-specific staining. Removal of high frequency background
(smoothing) was carried out either by low-pass filtering or a
morphology operation (opening) (Glasbey and Horgan, 1995). Cluster
and background pixels were discriminated with the entropy threshold
segmentation algorithm of Scil-Image, and the distribution of particle
sizes in this binary mask was determined with ScionImage (Scion
Corp., Frederick, MD). Cluster diameter was determined by
judiciously positioning the cursor on the screen on opposing edges of
the bright regions (Nagy et al., 1999b). In order to calculate the area
of overlap between clusters, segmented binary images (in which digit
1 and 0 correspond to cluster and background pixels, respectively)
recorded in the different fluorescence channels were multiplied with
each other. In the resulting image foreground pixels (value 1) reflect
the overlap of clusters in the two input images. The fractional overlap
was calculated by dividing the area of foreground pixels in the
resulting image by the area of foreground pixels in one of the original
images. Since this area was approximately the same in both original
images, we report only one of the obtained ratio values.
Flow cytometric energy transfer measurements
A modified Becton Dickinson FACStar Plus flow cytometer equipped
with dual argon ion laser excitation was used to measure the FRET
efficiency between fluorescently labeled membrane proteins. This
parameter is a quantitative measure of protein associations and can be
derived from three fluorescence intensities (Szöllo˝si et al., 1984). Two
intensities resulted from excitation at 488 nm and detection at 540±20
and above 580 nm, and the third signal was excited at 514 and detected
above 580 nm. Forward angle light scattering (at 514 nm) was used
to gate out debris. All data were stored in list mode format. FRET
efficiency was calculated on a cell-by-cell basis from the three
fluorescence intensities of 10,000 cells.
Flow cytometric measurement of antibody internalization
Three methods were used to detect antibody internalization. (1)
SKBR3 cells were incubated with unlabeled 4D5 (10 m g/ml) at 37°C.
Samples were taken every 10 minutes, and non-internalized ErbB2
was labeled with Alexa488-7C2 for 30 minutes on ice. Fluorescence
was detected with a FacsCalibur Flow Cytometer. (2) SKBR3 cells
were incubated in the presence of 10 m g/ml 4D5 antibody at 37°C.
The non-internalized fraction of 4D5 was labeled with Cy2-tagged
Fab fragments of anti-mouse IgG, and the fluorescence intensity of
Cy2 was measured on the flow cytometer. (3) SKBR3 cells were
treated with fluorescein labeled 4D5 antibody at 37°C. Samples taken
every 10 minutes were divided into two parts. Part 1 was subjected to
acid-wash (pH 2.4, 3 min) in order to remove 4D5 from the cell
surface (Baulida and Carpenter, 1997). Part 2 was not acid-treated.
The difference between the fluorescence intensities of these two
samples represented the amount of 4D5 on the cell surface.
Measurement of cell proliferation
50,000 cells were seeded in a culture dish and kept in the presence of
10% FCS for 1 day. They were subsequently incubated in medium
containing 0.1% FCS for 1 day. This was followed by a 5-day culture
in the presence of 10% FCS. In order to study the antiproliferative
effect of 4D5, 10 m g/ml of the antibody was added to the medium
with or without 8 m g/ml cholera toxin (subunit B). The culture
medium supplemented with 4D5 (and cholera toxin) was replenished
every second day. On day 5 the cells were counted and the cell surface
expression of ErbB2 was determined by labeling cells with Alexa488-
7C2.
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Measurement of tyrosine phosphorylation of ErbB2 and Shc
Cells were scraped off the culture substrate. Whole cell lysates of
control or stimulated cells were prepared by incubating the cells in
lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 10% (w/v) glycerol, 1
mM EGTA, 1% (w/v) Triton X-100, 1 mM Na3VO4, 1 mM PMSF,
Complete Mini protease inhibitor cocktail from Roche, pH 7.5) for 10
minutes on ice. The lysate was centrifuged at 12,000 g, and ErbB2 or
Shc was immunoprecipitated from the supernatant using OP15 and
sc-967 antibodies, respectively, and protein G beads. The
immunoprecipitates were run on SDS-polyacrylamide gels, and
blotted to nitrocellulose membranes. The membranes were probed
with anti-phosphotyrosine antibody PY99, then stripped and reprobed
with either anti-ErbB2 or anti-Shc antibodies to check whether
equivalent amounts of proteins were immunoprecipitated in each
sample. Bands on the blots were quantitated using enhanced
chemiluminescence (Amersham, Freiburg, Germany).
Results
ErbB2 homoassociation is not significantly different
inside and outside large-scale clusters
Previously we have found that the homoassociation of ErbB2
is uneven on the cell surface, i.e. there are membrane patches
with a diameter of ~ 0.5-1 m m in which ErbB2 homoassociation
is significantly higher than in the surrounding area (Nagy et al.,
1998). Later we have identified large-scale clusters of ErbB2
containing ~ 1000 ErbB2 proteins in which the density of
ErbB2 is 1-2 orders of magnitude higher than outside of them.
Their characteristic diameter is ~ 0.5 m m (Fig. 2A) (Nagy et al.,
1999b). The similar size of large-scale ErbB2 clusters and
membrane patches showing a high degree of ErbB2
homoassociation raised the possibility that the two might be
related. Therefore we measured the homoassociation of ErbB2
on a pixel-by-pixel basis using the donor pbFRET technique
in confocal microscopy (Jovin and Arndt Jovin, 1989) in order
to find out whether ErbB2 homoassociation was the same
inside and outside of large-scale clusters of ErbB2. The
fluorescence intensity of pixels outside large-scale clusters was
not high enough for reliable FRET measurements prompting
two approaches for increasing the signal-to-noise ratio. First,
large polygon-shaped regions of interest (ROI) were placed
separately on areas outside and inside large-scale clusters, and
the fluorescence intensity was summed inside these ROIs. The
FRET efficiency was calculated on the summed fluorescence
intensities. There was no significant difference between the
FRET efficiencies evaluated over pixels inside and outside the
large-scale clusters. In FRET experiments the FRET efficiency
is a measure of protein associations: the higher the FRET
efficiency is, the tighter the labeled proteins associate with each
other. Therefore, the lack of any significant difference in the
measured FRET efficiencies indicated that the
homoassociation of ErbB2 was the same inside and outside
ErbB2 clusters: FRET efficiencies for ErbB2 homoassociation
were 16±3% and 18±3% (mean – s.e.m.) for pixels inside and
outside ErbB2 clusters, respectively. According to the second
approach, the size of images was reduced in a way that square-
shaped areas (superpixels) consisting of 3· 3, 5· 5 or 7 · 7 pixels
were collapsed to a single pixel, the fluorescence intensity of
which was the summed intensity of the area it replaced.
Evaluation of the FRET efficiency was carried out on a pixel-
by-pixel basis on these compressed images, separately for
superpixels outside and inside large-scale clusters. These
calculations corroborated that there was no significant
difference between the homoassociation of ErbB2 inside and
outside large-scale clusters of this protein (FRET efficiencies
for ErbB2 homodimerization were 17±2% and 16±2% for
superpixels inside and outside large-scale ErbB2 clusters,
respectively, with all three sizes of superpixels).
ErbB2 homoassociation is influenced by the local
density of ErbB2 and ErbB3
Since the homoassociation of ErbB2 did not differ significantly
inside and outside large-scale clusters, we turned our attention
to the local densities of ErbB2 and ErbB3 as possible
determinants of ErbB2 homoassociation. SKBR-3 breast tumor
cells were labeled with FITC-4D5 and Cy3-4D5 as donor-
acceptor pair against ErbB2, and ErbB3 was labeled indirectly
using a Cy5-tagged secondary antibody. The homoassociation
of ErbB2 was calculated on a pixel-by-pixel basis using the
donor pbFRET technique and plotted as a function of the local
ErbB2 and ErbB3 densities. The analysis, carried out on pixels
inside ErbB2 clusters, showed that ErbB2 homoassociation
was positively correlated with the local density of the protein,
but negatively correlated with the local density of ErbB3 (Fig.
1). A very similar dependence of ErbB2 homoassociation on
the local densities of ErbB2 and ErbB3 was found outside
clusters; i.e. there were areas with high ErbB2 homoassociation
outside clusters as well (data not shown). However, the signal-
to-noise ratio was much lower in pixels outside clusters,
therefore we restricted our detailed analysis to the clusters.
Membrane patches with unusually high ErbB2
homoassociation were located in areas where the local density
of ErbB2 was high and that of ErbB3 was comparatively low
(Fig. 2A-C), as shown in Fig. 2D-F. In addition, for areas with
high ErbB2 intensity and very high ErbB3 density (as those
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Fig. 1. Dependence of ErbB2 homoassociation on local parameters.
SKBR-3 breast tumor cells were labeled with FITC-4D5 and Cy3-
4D5 against ErbB2 to measure the homoassociation of ErbB2; ErbB3
was labeled with Cy5-tagged secondary Fab following labeling with
H3.90.6. The homoassociation of ErbB2 was measured with the
donor pbFRET method, and it was correlated with the local density
of ErbB2 and ErbB3 on a pixel-by-pixel basis. The average FRET
efficiency for ErbB2 homoassociation is plotted as a function of the
local density of ErbB2 and ErbB3.
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marked with arrows in images A-C, Fig. 2), the
homoassociation of ErbB2 is lower than would be expected
from the high ErbB2 density alone. 
ErbB2 clusters colocalize with lipid rafts
Lipid rafts and lipid raft clusters are envisioned to be in the
range of ~ 10-1000 nm in size (Harder et al., 1998; Jacobson
and Dietrich, 1999; Anderson and Jacobson, 2002). Since lipid
rafts can serve as signal transduction platforms (Kurzchalia and
Parton, 1999), determining the colocalization between ErbB2
and lipid rafts is important and relevant. Lipid
rafts were visualized by labeling cells with
FITC-labeled subunit B of cholera toxin
(CTX-B), which binds GM1 ganglioside, a
lipid component highly abundant in lipid rafts
(Harder et al., 1998). ErbB2 was labeled with
Cy3-4D5. These experiments revealed that the
overlap between lipid rafts and ErbB2 clusters
was 77– 6% (Fig. 3A).
ErbB2 homoassociation is negatively
correlated with the density of GM1
We next examined the spatial relationship
between lipid rafts and the homoassociation of
ErbB2. Rafts were labeled with FITC-CTX-B,
and ErbB2 was labeled with a 1:1 mixture of
Cy3- and Cy5-tagged 4D5. ErbB2
homoassociation was measured with the
acceptor photobleaching technique. We found
a negative correlation between ErbB2
homoassociation and the fluorescence
intensity of FITC-CTX-B (Fig. 3A,B, Fig. 4).
We detected no FRET between FITC-CTX-B
and Cy3-4D5 (data not shown) implying that
the fluorescence intensity of FITC-CTX-B
reflected its local density. As CTX-B labels
GM1 ganglioside, an abundant lipid
component of lipid rafts, we concluded that
there was a negative correlation between
ErbB2 homoassociation and the local density
of the raft marker.
Cells were stimulated with EGF (50
ng/ml), heregulin (50 ng/ml) or MAb 4D5 (10
m g/ml) to determine whether the
colocalization between rafts and large-scale
clusters of ErbB2 was altered upon
activation. The colocalization of ErbB2
clusters and lipid rafts was not significantly
influenced by any of the above treatments, as
evidenced by similar cluster overlap values
(77 – 6% on control cells; 71 – 6%, 76 – 9% and
73 – 9% after stimulation with EGF, heregulin
and 4D5, respectively). We have previously
reported that the size of large-scale ErbB2
clusters increases upon stimulation of cells
with EGF, heregulin or 4D5 (Nagy et al.,
1999b). Thus, the fact that the overlap
between large-scale ErbB2 clusters and lipid
rafts did not change upon any of these
stimuli, suggested that the size of lipid rafts also increased
after stimulation with EGF, heregulin or 4D5. This
conclusion was confirmed by calculation of lipid raft
diameter, which increased from 0.43 – 0.02 m m in control cells
to 0.53 – 0.02 m m, 0.54 – 0.03 m m and 0.51 – 0.03 m m upon
stimulation with EGF, heregulin and 4D5, respectively
(P<0.05 for the increase; Fig. 3C). Since both the control and
the treated samples were labeled with FITC-CTX-B and
labeling was carried out on ice, we believe that the observed
increase in raft size was not due to pentavalent binding of
FITC-CTX-B.
Fig. 2. Membrane areas with anomalously high ErbB2 homoassociation colocalize
with membrane domains with high ErbB2 and comparatively low ErbB3 densities.
SKBR-3 breast tumor cells were labeled with FITC-4D5 and Cy3-4D5 against
ErbB2, and with unlabeled H3.90.6 anti-ErbB3 antibody followed by secondary
labeling with a Cy5-tagged Fab. Images A and B show the fluorescence intensity
distribution of Cy3-4D5 (ErbB2) and the Cy5-tagged secondary Fab (ErbB3),
respectively. The FRET efficiency for ErbB2 homoassociation is displayed in image
C. The areas inside the white polygons in image C have the highest FRET values.
The same areas are marked with red polygons in images A, B, D-F. These areas have
very high ErbB2 density and comparatively low ErbB3 density. The areas at the head
of the arrows have the highest ErbB2 and ErbB3 densities, but ErbB2
homoassociation in these pixels is lower than inside the marked areas. Image A was
thresholded, and pixels with high ErbB2 fluorescence intensity are white in image D,
whereas pixels with intensity below the threshold are black. Image B was ‘bi-
thresholded’: two intensity values were determined, and only pixels whose intensity
is between the two threshold values are white in image E, all other pixels are
displayed in black. Threshold values were adjusted so that white pixels in image E
have low ErbB3 intensities, but still above a certain level. Pixels with intensity values
lower than the lower threshold are background pixels, and they have to be excluded
from the analysis. In image F a pixel is displayed in white if the pixel is white in both
image D and E. The distributions of white areas in image F correlate with pixels with
high ErbB2 homoassociation in image C. Bar, 1 m m.
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CTX-B induces significant changes in the large-scale
association of ErbB2
In view of the inverse correlation between the density of GM1
ganglioside and ErbB2 homoassociation, we investigated
whether lipid raft crosslinking by CTX-B had any effect on
the association of ErbB2. CTX-B not only binds GM1, but
prolonged exposure of cells to CTX-B at 37°C can crosslink
lipid rafts and induce characteristic changes in the distribution
of membrane proteins (Harder et al., 1998). Cells were first
treated with 8 m g/ml FITC-CTX-B at 37°C for 30 minutes,
and then labeled with Cy3-4D5 Fab against ErbB2 on ice.
Analysis by confocal microscopy showed that the overlap
between lipid rafts and large-scale clusters of ErbB2
significantly (P<0.05) decreased to 29 – 9% (Fig. 3D),
implying that crosslinking of GM1 by CTX-B sequestered
these domains from ErbB2. By crosslinking GM1 CTX-B
induces translational diffusion of lipid rafts and the
accumulation of GM1 at sites of endocytosis (Nichols, 2002).
One possibility is that cytoskeletal anchoring of ErbB2 might
impede its movement with lipid rafts, resulting in ErbB2 being
left behind. However, disrupting microfilaments with
cytochalasin D treatment (10 m g/ml, 2.5 hours, 37°C) did not
perceivably modify the CTX-B-induced separation between
lipid rafts and large-scale clusters of ErbB2; the overlap
between lipid rafts and large-scale clusters of ErbB2 was
28 – 5% in CTX- and cytochalasin D-treated cells.
Cytochalasin D by itself did not change the colocalization
between ErbB2 clusters and lipid rafts, from which we
conclude that cytoskeletal anchoring was not responsible for
the inability of ErbB2 to move with lipid rafts.
Relationship between ErbB2 and caveolin clusters to
GM1-enriched domains
Caveolae are considered to be specialized lipid rafts, that can
be visualized with confocal microscopy (Kurzchalia and
Parton, 1999). In order to determine whether FITC-CTX-B-
labeled domains correspond to caveolae, we labeled SKBR-3
cells with an anti-caveolin antibody and FITC-CTX-B (Fig.
5A). There was an almost complete separation between
caveolae and the domains labeled by CTX-B as evidenced by
the low cluster overlap value (13±4%). This result suggested
that ErbB2 protein clusters, which colocalize with CTX-B,
should not overlap with caveolae. Indeed, we found only a
negligible colocalization between ErbB2 clusters and caveolae
(17±6%, Fig. 5B). However, CTX-B induced crosslinking of
GM1 induced its migration into caveolae, leaving ErbB2
clusters behind (Fig. 5C).
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Fig. 3. The relationship between lipid rafts and the
small- and large-scale clustering of ErbB2. (A,B)
SKBR-3 cells were labeled with FITC-CTX-B, Cy3-
4D5 and Cy5-4D5 Fab. The FITC (green) and Cy3
(red) channels are overlaid in image A. Yellow areas
correspond to colocalization between CTX-B-labeled
lipid rafts and ErbB2 clusters. The homoassociation of
ErbB2 was calculated using the acceptor
photobleaching FRET method, and the FRET efficiency
is displayed in panel B. FRET efficiency is color-coded
according to the color-scale. The white boxes mark
areas with inverse correlation between the local CTX-
labeling density and ErbB2 homoassociation: the
greener the area is in image A, the lower the FRET
efficiency is in the corresponding part of the cell in
image B. (C) Heregulin-stimulated SKBR-3 cells were
labeled with FITC-CTX-B and Cy3-4D5 Fab. (D)
SKBR-3 cells were treated with FITC-CTX-B at 37°C
for 30 minutes, and they were subsequently labeled
with Cy3-4D5 Fab. (E) SKBR-3 cells were pretreated
with FITC-CTX-B and then incubated with Cy3-4D5
antibody at 37°C for 30 minutes. In part A, C and E the
FITC image (green) is overlaid on the Cy3 (red) image.
Yellow areas correspond to significant colocalization
between lipid rafts and ErbB2 clusters. Bar, 1 m m.
Fig. 4. Lipid rafts influence the homoassociation of ErbB2. Lipid
rafts were visualized with FITC-CTX-B, and ErbB2 was labeled with
Cy3-4D5 and Cy5-4D5 antibodies in order to measure its
homoassociation with the acceptor photobleaching FRET method.
FRET efficiency was averaged in pixels with the same FITC-CTX
fluorescence intensity, and the average FRET efficiency is plotted as
a function of lipid raft labeling.
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CTX-B-induced changes in the small-scale association
of ErbB2
We investigated the small-scale association of ErbB2 in control
and CTX-B-treated cells using flow cytometric FRET
measurements. In these experiments, cells were treated with
unlabeled CTX-B, and then labeled with donor- and acceptor-
labeled antibodies against the ErbB proteins. The
heteroassociation of ErbB2 with ErbB3 significantly
decreased, but the homoassociation of ErbB2, and its
heteroassociation with ErbB1 was not affected by CTX-B
treatment (Fig. 6A). In control experiments, CTX-B treatment
did not change the expression level of ErbB1, ErbB2 and
ErbB3 implying that the measured changes in the FRET
efficiencies reflect alterations in protein association. One
possible origin for the decreased heteroassociation between
ErbB2 and ErbB3 is that CTX treatment separates ErbB2 but
not ErbB3 from lipid rafts. This would result in the separation
of large-scale clusters of ErbB2 and ErbB3, which would make
their heteroassociation impossible. However, confocal
microscopy showed that both ErbB2 and ErbB3 remained in
the same large-scale clusters after CTX treatment (data not
shown).
ErbB2 and Shc tyrosine phosphorylation induced by
EGF and heregulin in cells pretreated with CTX-B 
Since a heterodimer of ErbB2 and ErbB3 forms a functional
heregulin receptor, we expected a decreased effect of
this growth factor on CTX-B-pretreated SKBR-3 cells.
Control and CTX-B-pretreated samples were incubated
in the presence of heregulin or EGF. The tyrosine
phosphorylation of ErbB2 was high even in non-
stimulated cells, and neither EGF, nor heregulin was
able to elicit a significant increase in ErbB2 tyrosine
phosphorylation (0.05<P<0.1, Fig. 6B). In CTX-B-
pretreated cells, heregulin induced a marked decrease
in ErbB2 tyrosine phosphorylation, indicating a shift in
the balance between phosphorylation and
dephosphorylation towards the latter (P<0.01 for the
comparison between the heregulin-induced erbB2
tyrosine phosphorylation of CTX-B-pretreated and
non-treated samples). The lack of EGF-induced
response was unchanged in CTX-B-pretreated cells
(Fig. 6B). In order to observe a growth factor-elicited
response in SKBR-3 cells, we searched for a target
downstream of ErbB2 in the signal transduction
cascade. The tyrosine phosphorylation of Shc was
detectable even in unstimulated cells, and treatment
with either of EGF, heregulin or CTX-B induced an
increase in Shc tyrosine phosphorylation. Interestingly,
both EGF and heregulin induced a decrease in Shc
tyrosine phosphorylation when applied to CTX-B-
pretreated cells (Fig. 6B). 
CTX-B significantly alters the internalization and
antiproliferative effect of 4D5
The 4D5 antibody is a partial agonist of ErbB2, which
after inducing tyrosine phosphorylation of ErbB2,
efficiently downregulates the protein and blocks cell
proliferation (Sarup et al., 1991). We investigated
whether treatment of SKBR-3 cells with CTX-B alters 4D5-
induced ErbB2 downregulation and the cytostatic effect of the
antibody. According to flow cytometric measurements, ErbB2
was efficiently downregulated by 4D5 (Fig. 6C), a finding
consistent with previous reports (Sarup et al., 1991).
Furthermore, the downregulation was significantly blocked by
treatment of cells with CTX-B. Three flow cytometric methods
were used to monitor the downregulation of ErbB2 (described
in Materials and Methods), but only one of them is shown in
Fig. 6C, since results from the other approaches were the same.
Flow cytometry yields statistically reliable data but requires
cells in suspension. Therefore, we also used confocal
microscopy to detect the internalization of fluorescently
labeled 4D5 antibody and confirmed that treatment of SKBR-
3 cells with CTX-B blocks the accumulation of 4D5 in the
cytoplasm (Fig. 6D). We found previously that CTX-B
treatment segregates lipid rafts from clusters of ErbB2 (Fig.
3D). We wanted to determine how colocalization between lipid
rafts and ErbB2 clusters is influenced by co-treatment with
CTX-B and 4D5. The overlap between ErbB2 clusters and lipid
rafts was as low as in the case of cells treated with CTX-B
alone (Fig. 3E).
The 4D5 antibody blocks the proliferation of breast tumor
cells overexpressing ErbB2, and this effect is often attributed
to its ability to downregulate ErbB2. Therefore, we checked
whether treatment of cells with CTX-B influences the
cytostatic effect of 4D5. MAb 4D5 significantly blocked the
Fig. 5. Relationship between caveolin, GM1-enriched domains and ErbB2
clusters. (A) Quiescent SKBR-3 cells were labeled with FITC-CTX-B (green
channel) and with anti-caveolin antibody sc-894 followed by secondary
staining with Cy3-conjugated goat anti-rabbit immunoglobulin to visualize
sc-894 labeling (red channel). (B) Quiescent SKBR-3 cells were stained
against ErbB2 (with Alexa488-4D5, green channel) and against caveolin (as
in part A, red channel). (C) SKBR-3 cells were treated with FITC-CTX-B for
30 minutes at 37°C (green channel), and then stained against ErbB2 (Cy5-
4D5, blue channel) and against caveolin (as in part A, red channel). Bar,
1 m m.
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proliferation of SKBR-3 cells, and it reduced the amount of
ErbB2 on the cell surface (Fig. 6E). We expected that CTX-B
would hinder the antiproliferative effect of 4D5 since it
prevents the internalization of ErbB2 induced by 4D5.
However, 4D5 was even more efficient in blocking the
proliferation of SKBR-3 cells, if they were also treated with
CTX-B. CTX-B did not significantly influence the proliferation
of cells on its own but increased the amount of ErbB2 on the
cell surface (Fig. 6E).
Discussion
It has been known for years that overexpression of ErbB2
significantly alters the proliferation and motility of cells
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Fig. 6. CTX-induced effects in the association properties and biological
functions of ErbB2. (A) The homoassociation of ErbB2, and its
heteroassociation with ErbB1 and ErbB3 was measured with flow cytometry
on control cells (black bars) and cells pretreated with 8 m g/ml CTX-B at
37°C for 30 minutes (white bars). Error bars indicate the standard error of
the mean calculated from three independent experiments (*P<0.01).
(B) SKBR-3 cells were seeded in 6-well plates and starved for 48 hours.
CTX pretreatment was carried out in the presence of 8 m g/ml CTX-B at
37°C for 30 minutes, and then cells were stimulated with EGF or heregulin
for 10 minutes. The tyrosine phosphorylation of ErbB2 (left graph) and Shc
(right graph) was measured in control (black bars), EGF-stimulated (white
bars) and heregulin-stimulated (right hatched bars) samples. Membranes
labeled with anti-phosphotyrosine antibody were stripped and reprobed with
anti-ErbB2 or anti-Shc antibody. The phosphotyrosine content of the bands
was normalized to the amount of protein (ErbB2 or Shc)
immunoprecipitated and to the control samples. Asterisks indicate statistical
significance of Student’s t-test performed on non-stimulated and growth
factor-stimulated samples (*P<0.1, **P<0.05). Error bars indicate the standard error of the mean calculated from three independent
measurements. (C) Control (d) and CTX-pretreated (h) cells were incubated with unlabeled 4D5 antibody for 40 minutes. Samples were taken
every 10 minutes, and cell surface ErbB2 was labeled with Alexa488-7C2. The fluorescence intensity of Alexa488-7C2-labeled cells was
measured with flow cytometry. Error bars indicate the standard error of the mean (n=3). (D) Control and CTX-pretreated SKBR-3 cells were
incubated with Alexa488-4D5 antibody at 37°C for 30 minutes. Cells were imaged using confocal microscopy, and vertical slices of the cells
are shown. The approximate position of the cell membrane is marked with a black dashed line (bar, 1 m m). (E) 50,000 cells were seeded in
culture dishes. Control SKBR-3 cells and cells treated with 4D5, CTX-B and both with 4D5 and CTX-B were cultured for 5 days. Treatment
with the antibody and CTX-B was carried out as described in Materials and Methods. At day 5 the cell surface expression of ErbB2 was
measured with flow cytometry by labeling cells with Alexa488-7C2. The black bars show the mean fluorescence intensity after subtraction of
autofluorescence. The number of cells is shown by the white bars. Error bars indicate the standard error of the mean (*P<0.05 compared with
the corresponding control, n=3).
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(Spencer et al., 2000), and that it is associated with poor
prognosis (Slamon et al., 1987). Although many of these
effects are mediated by heterodimers between ErbB2 and other
ErbB proteins, ErbB2 homodimers are also present on the cell
surface, particularly in cells with c-ErbB2 gene amplification
and overexpression, and these homodimers confer phenotypic
effects that are likely different from that of various ErbB
heterodimers (Worthylake et al., 1999; Baeckstrom et al.,
2000). Although much has been learned about the association
properties of ErbB2, these studies failed to address the question
as to how local factors influence ErbB2 association.
Considering that focal activation of receptors is often observed
(Brock and Jovin, 2001) we investigated the distribution of
ErbB2 homoassociation in single cells.
Correlation between the association of ErbB2 and
ErbB3 and their expression densities
The homoassociation of ErbB2 correlated positively with the
local concentration of ErbB2, but negatively with ErbB3 local
density. Consequently, membrane areas with the highest ErbB2
homoassociation displayed high and low concentrations of
ErbB2 and ErbB3, respectively. The positive correlation
between the local density of ErbB2 and its homoassociation
probably resulted from a shift in the equilibrium between
monomers and dimers of ErbB2. It has already been suggested
that overexpression of ErbB2 results in constitutive
homodimerization of the protein, most probably induced by a
shift in the monomer-dimer equilibrium (Chamberlin and
Davies, 1998; Harris et al., 1999; Worthylake et al., 1999). Our
findings conform with and reinforce these previous results and
point to the possible existence of a monomer-dimer
equilibrium within single cells. The negative correlation
between ErbB2 homoassociation and ErbB3 local density
suggests that ErbB2-ErbB3 heterodimers compete with ErbB2
homodimers and therefore a high number of ErbB3 proteins
can disassemble ErbB2 homodimers. A similar conclusion has
already been reached based on previous work carried out on
whole cell populations (Tzahar et al., 1996), but our results
directly support such a competition in single cells.
Role of large-scale clustering in ErbB2 homoassociation
We have previously identified a second hierarchical level of
ErbB2 association termed large-scale clustering (Nagy et al.,
1999b). These large-scale clusters of ErbB2 contain ~ 103
ErbB2 proteins and their diameter is ~ 0.5 m m in unstimulated
SKBR-3 cells. We found that the extent of ErbB2
homoassociation inside clusters is not significantly different
from that outside clusters. The fact that ErbB2 homoassociates
even outside clusters, where the local density of the protein is
low, suggests that it very avidly forms homodimers. Based on
the positive correlation between the local density of ErbB2 and
its homoassociation one would expect the extent of ErbB2
homoassociation to be higher inside clusters than outside. We
can offer two alternative explanations. (1) The local
concentration of ErbB3 is also higher inside clusters (Fig. 2B).
Since ErbB3-ErbB2 dimers are preferentially formed (Tzahar
et al., 1996), the higher number of ErbB3 proteins can
efficiently counterbalance the effect of the increased density of
ErbB2. (2) Large-scale clusters of ErbB2 colocalize with lipid
rafts, where the lipid environment decreases ErbB2
homoassociation (Figs 3, 4). Lipid rafts contain a high amount
of lipids with saturated fatty acids, cholesterol and
sphingolipids, and present an environment for ErbB2 that is
markedly different from the bulk lipid phase. This environment
might alter the association properties of ErbB2, as previously
reported for another membrane protein (Vereb et al., 2000).
Involvement of lipid rafts in the association of ErbB2
According to our results ErbB2 is preferentially localized in
lipid rafts. Fluorescent labeling of caveolin revealed that GM1-
enriched membrane domains do not colocalize with caveolae,
but crosslinking of GM1 by CTX-B induces migration of GM1
into caveolae (Fig. 5). It has been reported that GM1 appears
in separate, non-caveolar membrane domains (Vyas et al.,
2001), but accumulates in caveolae after crosslinking by CTX
(Orlandi and Fishman, 1998; Nichols, 2002). Our results are
in agreement with the above, and corroborate the existence of
distinct classes of raft-like membrane domains. 
Identification of a membrane protein as raft-associated is
usually based on its presence in the detergent-insoluble phase
of the membrane. However, this criterion is of uncertain value,
because it necessitates disruption of the plasma membrane and
is dependent on the nature of the detergent used (Jacobson and
Dietrich, 1999). Labeling with CTX-B is accepted as a reliable
raft marker (Harder et al., 1998), and application of
microscopy-based approaches for the identification of raft-
associated proteins has the advantage of dealing with intact
plasma membranes (Jacobson and Dietrich, 1999; Kenworthy
et al., 2000). The size of the domains identified by FITC-CTX-
B labeling is larger than the currently accepted size of lipid
rafts. However, it is acknowledged that the size and nature of
lipid rafts depend upon the method of investigation (Edidin,
2001). We believe that FITC-CTX-B labeling reliably
identifies lipid rafts or clusters of them.
In contrast to GPI-anchored proteins, which co-patch with
CTX-B (Harder et al., 1998), lipid rafts are sequestered from
ErbB2 after crosslinking with CTX-B implying a weaker
interaction between raft lipids and ErbB2. Segregation of
ErbB2 from lipid rafts after CTX-B treatment is not inhibited
by disruption of microfilaments suggesting that cytoskeletal
anchoring does not influence the raft-association of the protein.
We propose that crosslinking of rafts initiates their translational
diffusion in the plasma membrane, and that GPI-anchored
proteins follow these motions. However, ErbB2, which has a
lower lateral diffusion constant due to its transmembrane and
intracellular domains, may fail to ‘keep up’ with the more
dynamic rafts, also suggesting a less stable localization of
ErbB2 in lipid rafts compared to GPI-anchored proteins.
The finding that ErbB2 is dislodged from lipid rafts and gets
into the bulk lipid phase upon CTX-B treatment offered a
possibility for investigating the effects of lipid environment
changes on the association properties and biological function
of ErbB2. Treatment of cells with CTX-B decreased the
heteroassociation of ErbB2 with ErbB3, leading to inhibited
tyrosine phosphorylation of Shc upon treatment with heregulin,
the ligand of the ErbB2-ErbB3 heterodimer. Although the anti-
Shc antibody we used recognizes both the 46 and 52 kDa forms
of Shc, present in SKBR-3 cells (Le et al., 2000), we could
only detect a single band. We cannot offer a rationale for this
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result or for the lack of growth factor-induced tyrosine
phosphorylation of ErbB2. It has already been observed by
other authors that heregulin induces a hardly detectable
increase in the tyrosine phosphorylation of ErbB2 (Le et al.,
2000). This may be caused by the very high level of
overexpression of ErbB2 in this cell line leading to self-
activation of the protein (Worthylake et al., 1999). Our cell line
may also be slightly different from the one used by Le and co-
workers (Le et al., 2000). Neither ErbB2 homoassociation nor
its heteroassociation with ErbB1 was affected by treatment
with CTX-B. The fact that the EGF-induced tyrosine
phosphorylation of ErbB2 was the same in control and CTX-
B-pretreated cells accords nicely with this finding. However,
the EGF-induced tyrosine phosphorylation of Shc was
inhibited in CTX-B-pretreated cells. Previous reports
suggested that Shc activation takes place inside rafts (Plyte et
al., 2000), leading to the logical conclusion that ErbB2 located
outside lipid rafts may not be able to activate Shc.
Internalization of ErbB2 in CTX-B-pretreated cells
Internalization of ErbB2 induced by 4D5 was significantly
inhibited in cells pretreated with CTX-B. The antiproliferative
effect of 4D5 is thought to be related to ErbB2 internalization
followed by intracellular degradation (Sarup et al., 1991;
Klapper et al., 2000; Levkowitz et al., 2000). Therefore, we
expected that inhibition of ErbB2 internalization by CTX-B
would be associated with decreased downregulation of ErbB2,
and consequently with a decrease in the antiproliferative effect
of 4D5. However, the antiproliferative effect of 4D5 was even
higher in cells treated with CTX-B, suggesting that antibody-
induced short-term internalization may not be a good marker
for the selection of antibodies with antiproliferative effect. This
proposal is in agreement with data obtained by Neve and co-
workers (Neve et al., 2001), who used a single chain antibody
that downregulates ErbB2 very efficiently without exerting any
effect on either MAPK activity or cell proliferation. The
increased cell surface expression of ErbB2 in cells treated with
CTX-B alone may reflect decreased internalization of ErbB2
with a consequent shift in the equilibrium between transport of
ErbB2 to and from the membrane. We do not know the reason
for the increased cytostatic effect of 4D5 observed in cells
treated with CTX-B. It is possible that although CTX-B slows
down activation-induced internalization of ErbB2, small
amounts of ErbB2 might still get internalized and degraded by
a cbl-mediated pathway resulting in reduced cell proliferation
(Klapper et al., 2000).
Model for the role of lipid rafts and the local density of
ErbB proteins in their association
ErbB proteins form homo- and heterodimers at the molecular
level and large-scale clusters in the membrane. The latter
colocalize with GM1-enriched membrane domains, but are
distinct from caveolae. GM1 leaves ErbB protein clusters
behind upon crosslinking by CTX-B and migrates into
caveolae (Fig. 7). A high local density of ErbB proteins in
clusters favors their spontaneous activation, which is kept
under control by the special lipid environment of rafts, that
decreases ErbB2 homoassociation. A role of lipid rafts in
limiting the autoactivation of the ErbB signaling system is
supported by the increased tyrosine phosphorylation of Shc
after CTX-B treatment (Fig. 6B), which removes ErbB proteins
from rafts (Fig. 3D). On the other hand, lipid rafts are also
responsible for maintaining ErbB proteins in a growth factor
responsive state. This is supported by the following results. (1)
Neither EGF, nor heregulin is able to activate Shc, if ErbB
proteins are removed from lipid rafts (Fig. 6B). (2) The
formation of heregulin-responsive ErbB2-ErbB3 heterodimers
and heregulin-induced ErbB2 tyrosine phosphorylation
decrease, if ErbB proteins are removed from lipid rafts (Fig.
6A,B). These results parallel the suggested role of lipid rafts
in T-cell-receptor-mediated signaling, where rafts are thought
to be the storage sites of antigen responsive, inactive signaling
components (Germain, 2001).
In summary, we have provided evidence for the role of local
factors in influencing ErbB2 homoassociation. Temporal
fluctuations in these factors may generate local
inhomogeneities in ErbB2 homoassociation and local
anomalies in signal transduction. In addition to a more
thorough understanding of the complexity of the ErbB
network, these results may facilitate the development of more
efficient therapeutic strategies for breast cancer.
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Fig. 7. Model for the association of ErbB proteins inside and outside
clusters. The extent of ErbB2-ErbB2 and ErbB2-ErbB3 associations
depend on the relative expression levels of the proteins: high local
ErbB3 density decreases ErbB2 homoassociation. Lipid rafts, which
were identified as GM1-enriched domains labeled by CTX-B in our
studies, colocalize with ErbB protein clusters. Although the high
local concentration of ErbB proteins inside clusters favors their
spontaneous activation (e.g. the formation of highly active ErbB2
homodimers), lipid rafts keep the activation of ErbB2 under control
by limiting the homodimerization of ErbB2. By contrast, ErbB
proteins are maintained in a signaling competent form inside rafts
(i.e. heregulin-responsive ErbB2-ErbB3 heterodimers are present),
which are disassembled if ErbB proteins are removed from them.
CTX-B treatment induces migration of GM1-enriched domains into
caveolae and disrupts ErbB2-ErbB3, but not ErbB2-ErbB2 or ErbB2-
ErbB1 dimers.
4261Lipid rafts and association of ErbB proteins
References
Alroy, I. and Yarden, Y. (1997). The ErbB signaling network in
embryogenesis and oncogenesis: signal diversification through
combinatorial ligand-receptor interactions. FEBS Lett. 410, 83-86.
Anderson, R. G. and Jacobson, K. (2002). A role for lipid shells in targeting
proteins to caveolae, rafts, and other lipid domains. Science 296, 1821-1825.
Baeckstrom, D., Alford, D. and Taylor, P. J. (2000). Morphogenetic and
proliferative responses to heregulin of mammary epithelial cells in vitro are
dependent on HER2 and HER3 and differ from the responses to HER2
homodimerisation or hepatocyte growth factor. Int. J. Oncol. 16, 1081-1090.
Baulida, J. and Carpenter, G. (1997). Heregulin degradation in the absence
of rapid receptor-mediated internalization. Exp. Cell Res. 232, 167-172.
Baulida, J., Kraus, M. H., Alimandi, M., di Fiore, P. P. and Carpenter, G.
(1996). All ErbB receptors other than the epidermal growth factor receptor
are endocytosis impaired. J. Biol. Chem. 271, 5251-5257.
Bodnár, A., Jenei, A., Bene, L., Damjanovich, S. and Matkó, J. (1996).
Modification of membrane cholesterol level affects expression and
clustering of class I HLA molecules at the surface of JY human
lymphoblasts. Immunol. Lett. 54, 221-226.
Brock, R. and Jovin, T. M. (2001). Heterogeneity of signal transduction at
the subcellular level: microsphere-based focal EGF receptor activation and
stimulation of Shc translocation. J. Cell Sci. 114, 2437-2447.
Chamberlin, S. G. and Davies, D. E. (1998). A unified model of c-erbB
receptor homo- and heterodimerisation. Biochim. Biophys. Acta 1384, 223-
232.
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S.,
Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G. et
al. (1999). Multinational study of the efficacy and safety of humanized anti-
HER2 monoclonal antibody in women who have HER2-overexpressing
metastatic breast cancer that has progressed after chemotherapy for
metastatic disease. J. Clin. Oncol. 17, 2639-2648.
Demandolx, D. and Davoust, J. (1997). Multiparameter image cytometry:
from confocal micrographs to subcellular fluorograms. Bioimaging 5, 159-
169.
Edidin, M. (2001). Shrinking patches and slippery rafts: scales of domains in
the plasma membrane. Trends Cell Biol. 11, 492-496.
Furuchi, T. and Anderson, R. G. (1998). Cholesterol depletion of caveolae
causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol.
Chem. 273, 21099-21104.
Germain, R. N. (2001). The T cell receptor for antigen: signaling and ligand
discrimination. J. Biol. Chem. 276, 35223-35226.
Glasbey, C. A. and Horgan, G. W. (1995). Mathematical morphology. In
Image Analysis for the Biological Sciences (ed. C. A. Glasbey and G. W.
Horgan), pp. 125-152. John Wiley & Sons.
Graus Porta, D., Beerli, R. R., Daly, J. M. and Hynes, N. E. (1997). ErbB-
2, the preferred heterodimerization partner of all ErbB receptors, is a
mediator of lateral signaling. EMBO J. 16, 1647-1655.
Harder, T. and Simons, K. (1997). Caveolae, DIGs, and the dynamics of
sphingolipid-cholesterol microdomains. Curr. Opin. Cell Biol. 9, 534-542.
Harder, T., Scheiffele, P., Verkade, P. and Simons, K. (1998). Lipid domain
structure of the plasma membrane revealed by patching of membrane
components. J. Cell Biol. 141, 929-942.
Harris, R. A., Eichholtz, T. J., Hiles, I. D., Page, M. J. and O’Hare, M. J.
(1999). New model of ErbB-2 over-expression in human mammary luminal
epithelial cells. Int. J. Cancer 80, 477-484.
Hwang, J., Gheber, L. A., Margolis, L. and Edidin, M. (1998). Domains in
cell plasma membranes investigated by near-field scanning optical
microscopy. Biophys. J. 74, 2184-2190.
Ilangumaran, S., Arni, S., van Echten-Deckert, G., Borisch, B. and
Hoessli, D. C. (1999). Microdomain-dependent regulation of Lck and Fyn
protein-tyrosine kinases in T lymphocyte plasma membranes. Mol. Biol.
Cell 10, 891-905.
Jacobson, K. and Dietrich, C. (1999). Looking at lipid rafts? Trends. Cell
Biol. 9, 87-91.
Janes, P. W., Ley, S. C. and Magee, A. I. (1999). Aggregation of lipid rafts
accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147, 447-
461.
Jovin, T. M. and Arndt Jovin, D. J. (1989). FRET microscopy: Digital
imaging of fluorescence resonance energy transfer. Application in cell
biology. In Cell Structure and Function by Microspectrofluorometry (ed. E.
Kohen and J. G. Hirschberg), pp. 99-117. San Diego, CA: Academic Press.
Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus Porta, D.,
Ratzkin, B. J., Seger, R., Hynes, N. E. and Yarden, Y. (1996). ErbB-2 is
a common auxiliary subunit of NDF and EGF receptors: implications for
breast cancer. EMBO J. 15, 254-264.
Kenworthy, A. K., Petranova, N. and Edidin, M. (2000). High-resolution
FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in
cell plasma membranes. Mol. Biol. Cell 11, 1645-1655.
Klapper, L. N., Waterman, H., Sela, M. and Yarden, Y. (2000). Tumor-
inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and
enhancing ubiquitination of HER-2. Cancer Res. 60, 3384-3388.
Kurzchalia, T. V. and Parton, R. G. (1999). Membrane microdomains and
caveolae. Curr. Opin. Cell Biol. 11, 424-431.
Le, X. F., Vadlamudi, R., McWatters, A., Bae, D. S., Mills, G. B., Kumar,
R. and Bast, R. C.,  Jr (2000). Differential signaling by an anti-
p185(HER2) antibody and heregulin. Cancer Res. 60, 3522-3531.
Levkowitz, G., Klapper, L. N., Tzahar, E., Freywald, A., Sela, M. and
Yarden, Y. (1996). Coupling of the c-Cbl protooncogene product to ErbB-
1/EGF- receptor but not to other ErbB proteins. Oncogene 12, 1117-1125.
Levkowitz, G., Oved, S., Klapper, L. N., Harari, D., Lavi, S., Sela, M. and
Yarden, Y. (2000). c-Cbl is a suppressor of the neu oncogene. J. Biol. Chem.
275, 35532-35539.
Matkó, J., Bodnár, A., Vereb, G., Bene, L., Vámosi, G., Szentesi, G.,
Szöllo˝si, J., Gáspár, R., Jr, Horejsi, V., Waldmann, T. A. et al. (2002).
GPI-microdomains (membrane rafts) and signaling of the multi-chain
interleukin-2 receptor in human lymphoma/leukemia T cell lines. Eur. J.
Biochem. 269, 1199-1208.
Mineo, C., Gill, G. N. and Anderson, R. G. (1999). Regulated migration of
epidermal growth factor receptor from caveolae. J. Biol. Chem. 274, 30636-
30643.
Nagy, P., Bene, L., Balázs, M., Hyun, W. C., Lockett, S. J., Chiang, N. Y.,
Waldman, F. M., Feuerstein, B. G., Damjanovich, S. and Szöllo˝si, J.
(1998). EGF-induced redistribution of erbB2 on breast tumor cells: Flow
and image cytometric energy transfer measurements. Cytometry 32, 120-
131.
Nagy, P., Jenei, A., Damjanovich, S., Jovin, T. M. and Szöllo˝si, J. (1999a).
Complexity of signal transduction mediated by erbB2: clues to the potential
of receptor-targeted cancer therapy. Pathol. Oncol. Res. 5, 255-271.
Nagy, P., Jenei, A., Kirsch, A. K., Szöllo˝si, J., Damjanovich, S. and Jovin,
T. M. (1999b). Activation-dependent clustering of the erbB2 receptor
tyrosine kinase detected by scanning near-field optical microscopy. J. Cell
Sci. 112, 1733-1741.
Neve, R. M., Nielsen, U. B., Kirpotin, D., Poul, M. A., Marks, J. D. and
Benz, C. C. (2001). Biological effects of anti-ErbB2 single chain antibodies
selected for internalizing function. Biochem. Biophys. Res. Commun. 280,
274-279.
Nichols, B. J. (2002). A distinct class of endosome mediates clathrin-
independent endocytosis to the Golgi complex. Nat. Cell Biol. 4, 374-378.
Orlandi, P. A. and Fishman, P. H. (1998). Filipin-dependent inhibition of
cholera toxin: evidence for toxin internalization and activation through
caveolae-like domains. J. Cell Biol. 141, 905-915.
Park, J. W., Tripathy, D., Campbell, M. J. and Esserman, L. J. (2000).
Biological therapy of breast cancer. Biodrugs 14, 221-245.
Pinkas Kramarski, R., Shelly, M., Glathe, S., Ratzkin, B. J. and Yarden,
Y. (1996). Neu differentiation factor/neuregulin isoforms activate distinct
receptor combinations. J. Biol. Chem. 271, 19029-19032.
Plyte, S., Majolini, M. B., Pacini, S., Scarpini, F., Bianchini, C.,
Lanfrancone, L., Pelicci, P. and Baldari, C. T. (2000). Constitutive
activation of the Ras/MAP kinase pathway and enhanced TCR signaling by
targeting the Shc adaptor to membrane rafts. Oncogene 19, 1529-1537.
Pralle, A., Keller, P., Florin, E. L., Simons, K. and Horber, J. K. (2000).
Sphingolipid-cholesterol rafts diffuse as small entities in the plasma
membrane of mammalian cells. J. Cell Biol. 148, 997-1008.
Sarup, J. C., Johnson, R. M., King, K. L., Fendly, B. M., Lipari, M. T.,
Napier, M. A., Ullrich, A. and Shepard, H. M. (1991). Characterization
of an anti-p185HER2 monoclonal antibody that stimulates receptor function
and inhibits tumor cell growth. Growth Regul. 1, 72-82.
Simons, K. and Ikonen, E. (1997). Functional rafts in cell membranes. Nature
387, 569-572.
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A. and
McGuire, W. L. (1987). Human breast cancer: correlation of relapse and
survival with amplification of the HER-2/neu oncogene. Science 235, 177-
182.
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V.,
Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M. et
al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2
4262
for metastatic breast cancer that overexpresses HER2. New Engl. J. Med.
344, 783-792.
Sliwkowski, M. X., Lofgren, J. A., Lewis, G. D., Hotaling, T. E., Fendly,
B. M. and Fox, J. A. (1999). Nonclinical studies addressing the mechanism
of action of trastuzumab (Herceptin). Semin. Oncol. 26, 60-70.
Spencer, K. S. R., Graus, P., Leng, J., Hynes, N. E. and Klemke, R. L.
(2000). ErbB2 is necessary for induction of carcinoma cell invasion by ErbB
family receptor tyrosine kinases. J. Cell Biol. 148, 385-397.
Szöllo˝si, J., Trón, L., Damjanovich, S., Helliwell, S. H., Arndt Jovin, D.
and Jovin, T. M. (1984). Fluorescence energy transfer measurements on
cell surfaces: a critical comparison of steady-state fluorimetric and flow
cytometric methods. Cytometry 5, 210-216.
Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D.,
Lavi, S., Ratzkin, B. J. and Yarden, Y. (1996). A hierarchical network of
interreceptor interactions determines signal transduction by Neu
differentiation factor/neuregulin and epidermal growth factor. Mol. Cell.
Biol. 16, 5276-5287.
Vereb, G., Matkó, J., Vamosi, G., Ibrahim, S. M., Magyar, E., Varga, S.,
Szöllo˝si, J., Jenei, A., Gáspár, R., Jr, Waldmann, T. A. et al. (2000).
Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with
HLA and CD48 on T lymphoma cells suggest their functional association
with lipid rafts. Proc. Natl. Acad. Sci. USA 97, 6013-6018.
Vyas, K. A., Patel, H. V., Vyas, A. A. and Schnaar, R. L. (2001). Segregation
of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts,
and defined supported lipid monolayers. Biol. Chem. 382, 241-250.
Worthylake, R., Opresko, L. K. and Wiley, H. S. (1999). ErbB-2
amplification inhibits down-regulation and induces constitutive activation of
both erbB-2 and epidermal growth factor receptors. J. Biol. Chem. 274,
8865-8874.
Wouters, F. S., Bastiaens, P. I., Wirtz, K. W. and Jovin, T. M. (1998). FRET
microscopy demonstrates molecular association of non-specific lipid
transfer protein (nsL-TP) with fatty acid oxidation enzymes in peroxisomes.
EMBO J. 17, 7179-7189.
Yarden, Y. and Sliwkowski, M. X. (2001). Untangling the ErbB signalling
network. Nat. Rev. Mol. Cell. Biol. 2, 127-137.
Journal of Cell Science 115 (22)
